“Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind Studies”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 1, Jan. 2021, p. s8, https://doi.org/10.25251/skin.5.supp.8.